ACUTE ORAL TOXICITY OF TOFACITINIB CITRATE IN WISTAR RATS: IMPLICATIONS FOR NOVEL MOUTH DISSOLVING FORMULATIONS
DOI:
https://doi.org/10.22159/ijap.2024v16i3.48787Keywords:
Tofacitinib citrate, Acute oral toxicity, Mouth dissolving formulations, Food consumption, Water consumption, Hematological analysis, Biochemical analysis, Organ histopathologyAbstract
Objective: Tofacitinib citrate is a commonly used therapeutic agent for various diseases. Mouth-dissolving formulations provide potential benefits for patient compliance. This study aims to evaluate the acute oral toxicity of tofacitinib citrate in these formulations to ensure their safety and efficacy.
Methods: This study aimed to assess the acute oral toxicity of tofacitinib citrate in mouth-dissolving formulations and evaluate its effects on food and water consumption, hematological and biochemical parameters, and organ histopathology. Male and female Wistar rats were divided into four groups. The control group received distilled water, while the treated groups were orally administered tofacitinib citrate at 5 mg/kg, 100 mg/kg, and 300 mg/kg. Observations were made over 14 d, assessing general appearance, behavior, food and water consumption, and mortality. Hematological and biochemical analyses and histopathological examinations were conducted on vital organs.
Results: In acute toxicity studies, Wistar rats showed no toxicity at up to 300 mg/kg tofacitinib citrate. Compared to controls, food/water intake and hematological, biochemical, and histopathological parameters of major organs remained unchanged, indicating no systemic effects and affirming the compound's safety in mouth-dissolving formulations.
Conclusion: Tofacitinib citrate in mouth-dissolving formulations demonstrated a favorable safety profile with no acute oral toxicity. Normal consumption, unchanged parameters, and no organ abnormalities support its safety. Further investigation is required to assess chronic toxicity and long-term safety.
Downloads
References
Farooqui P, Gude R. Formulation development and optimisation of fast dissolving Buccal films loaded glimepiride solid dispersion with enhanced dissolution profile using central composite design. Int J Pharm Pharm Sci. 2023 May;5(6):35-54. doi: 10.22159/ijpps.2023v15i6.47992.
Cada DJ, Demaris K, Levien TL, Baker DE. Tofacitinib. Hosp Pharm. 2013 May;48(5):413-24. doi: 10.1310/hpj4805-413, PMID 24421498.
Raykar M, Velraj M. Design, development and evaluation of mouth dissolving tablets of tofacitinib citrate. Int J App Pharm. 2022 Jan 1;14(1):238-45. doi: 10.22159/ijap.2022v14i1.42810.
Raykar M, Velraj M. Design, development and evaluation of novel mouth dissolving film of tofacitinib citrate. Int J App Pharm. 2023 Jan;15(1):324-32. doi: 10.22159/ijap.2023v15i1.46064.
Kennedy Crispin M, Ko JM, Craiglow BG, Li S, Shankar G, Urban JR. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight. 2016 Sep 22;1(15):e89776. doi: 10.1172/jci.insight.89776, PMID 27699252.
Asahina A, Etoh T, Igarashi A, Imafuku S, Saeki H, Shibasaki Y. Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: a randomized, double-blind, phase 3 study. J Dermatol. 2016 Aug 1;43(8):869-80. doi: 10.1111/1346-8138.13258, PMID 26875540.
Murwanti R, Nurrochmad A, Gani AP, Sasmito E, Edwina AE, Chandra MK. Acute and subchronic oral toxicity evaluation of herbal formulation: piper crocatum ruiz and pav., typhonium flagelliforme (Lodd.) blume, and phyllanthus niruri L. in Sprague-Dawley rats. J Toxicol. 2023;2023:7511397. doi: 10.1155/2023/7511397, PMID 36636256.
Kennedy GL, Ferenz RL, Burgess BA. Estimation of acute oral toxicity in rats by determination of the approximate lethal dose rather than the LD50. J Appl Toxicol. 1986 Jun 1;6(3):145-8. doi: 10.1002/jat.2550060302, PMID 3722708.
Balijepalli MK, Suppaiah V, Chin AM, Buru AS, Sagineedu SR, Pichika MR. Acute oral toxicity studies of swietenia macrophylla seeds in sprague dawley rats. Pharmacognosy Res. 2015 Jan-Mar;7(1):38-44. doi: 10.4103/0974-8490.147197, PMID 25598633, PMCID PMC4285647.
Test No. 408: Repeated dose 90 d oral toxicity study; 2018 Jun 27. Available from: https://www.oecd-ilibrary.org/environment/test-no-408-repeated-dose-90-day-oral-toxicity-study-in-rodents_9789264070707-en [Last accessed on 07 Jul 2023]
Chanda S, Dave R, Kaneria M, Shukla V. Acute oral toxicity of polyalthia longifolia var. pendula leaf extract in wistar albino rats. Pharm Biol. 2012 Nov;50(11):1408-15. doi: 10.3109/13880209.2012.682117, PMID 22849547.
Porwal M, Khan NA, Maheshwari KK. Evaluation of acute and subacute oral toxicity induced by ethanolic extract of marsdenia tenacissima leaves in experimental rats. Sci Pharm. 2017 Aug 21;85(3):29. doi: 10.3390/scipharm85030029, PMID 28825665.
Prabu PC, Panchapakesan S, Raj CD. Acute and sub-acute oral toxicity assessment of the hydroalcoholic extract of Withania somnifera roots in wistar rats. Phytother Res. 2013 Aug 1;27(8):1169-78. doi: 10.1002/ptr.4854, PMID 22996349.
Da Silva RO, Andrade VM, Bulle Rego ES, Azevedo Doria GA, Dos Santos Lima BD, Da Silva FA. Acute and sub-acute oral toxicity of Brazilian red propolis in rats. J Ethnopharmacol. 2015 Jul 21;170:66-71. doi: 10.1016/j.jep.2015.05.009, PMID 25978955.
Al-Afifi NA, Alabsi AM, Bakri MM, Ramanathan A. Acute and sub-acute oral toxicity of dracaena cinnabari resin methanol extract in rats. BMC Complement Altern Med. 2018;18(1):50. doi: 10.1186/s12906-018-2110-3, PMID 29402248.
Morales G, Paredes A, Olivares A, Bravo J. Acute oral toxicity and anti-inflammatory activity of hydroalcoholic extract from Lampaya medicinalis phil in rats. Biol Res. 2014 Mar 26;47(1):6. doi: 10.1186/0717-6287-47-6, PMID 25027298.
Committee for Medicinal Products for Human Use (CHMP) Assessment report. Tofacitinib citrate; 2013. Available from: www.ema.europa.eu
Santhoshkumar B. Aute toxicity study of therapeutic activity of modified arjunarishta on isoproterenol-induced myocardial infarction in rats. Int J Pharm Pharm Sci. 2022 Mar 12;14(5):12-21.
Sari LM. Acute oral toxicity study of areca catechu linn. Aqueous extract in sprague dawley rats. Asian J Pharm Clin Res. 2016 Dec 1;9(3):1-3.
Brown PC. Center for drug evaluation and research application number: 203214Orig1s000; 2011.
Xeljanz, Xeljanz XR. Nonclinical toxicology (tofacitinib). Available from: https://www.pfizermedicalinformation.com/en-us/xeljanz/nonclinical-toxicology [Last accessed on 07 Jul 2023]
Sperottova S, Matalova P. Tofacitinib. Interni Med Pro Praxi. 2021 Jul 21;21(5):292-4.
Published
How to Cite
Issue
Section
Copyright (c) 2024 MEGHANA RAYKAR, MALARKODI VELRAJ
This work is licensed under a Creative Commons Attribution 4.0 International License.
